{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-10-29T12:24:27.101295+00:00",
  "news": [
    {
      "title": "Earnings Preview: Amgen (AMGN) Q3 Earnings Expected to Decline - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxNWXVyRHlaNENCWWZWUkR2QXlMTG1iRmpubENaTU0zeTY1VVBwMnNwY1l5UGJxZDhyQk9rZlIzRlVCLWxOSkd3UkNuMnBseXRPMC1IeGpjanNWWHdjbDlOUFdON3lEcnRUN0VzNWl1WkY3aGhwVF9pdkFXb0E1MVVxb0hn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxNWXVyRHlaNENCWWZWUkR2QXlMTG1iRmpubENaTU0zeTY1VVBwMnNwY1l5UGJxZDhyQk9rZlIzRlVCLWxOSkd3UkNuMnBseXRPMC1IeGpjanNWWHdjbDlOUFdON3lEcnRUN0VzNWl1WkY3aGhwVF9pdkFXb0E1MVVxb0hn?oc=5\" target=\"_blank\">Earnings Preview: Amgen (AMGN) Q3 Earnings Expected to Decline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-28T14:00:07+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Strategic Financial Services Inc. Purchases Shares of 1,217 Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNWndTZ2kzTjZtRDJIcWxXN0FPaUhuNVhva2cyVzNSUzFjRXlIZ0tyYnlOY3E1SHRNa1pJVEVyNmE0UzdMR0I4cWNSUkxCZ1pNWlFsSlN6WU9ObmtRdDN0OThFX096ZU1QWjgzS2Z2dHNLZ2VNQVpFcWZkZU9yNWVtTWNCYUs3aW1wZVBZUTlKUzFCTzJWWE9peXl2MGdpMzBtVmFZa1l2VDhueHp4YW1NV3BFTnRIU3M3UXA2WlVQVm9hc0lUVFhoNWhZZ0xHdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMizgFBVV95cUxNWndTZ2kzTjZtRDJIcWxXN0FPaUhuNVhva2cyVzNSUzFjRXlIZ0tyYnlOY3E1SHRNa1pJVEVyNmE0UzdMR0I4cWNSUkxCZ1pNWlFsSlN6WU9ObmtRdDN0OThFX096ZU1QWjgzS2Z2dHNLZ2VNQVpFcWZkZU9yNWVtTWNCYUs3aW1wZVBZUTlKUzFCTzJWWE9peXl2MGdpMzBtVmFZa1l2VDhueHp4YW1NV3BFTnRIU3M3UXA2WlVQVm9hc0lUVFhoNWhZZ0xHdw?oc=5\" target=\"_blank\">Strategic Financial Services Inc. Purchases Shares of 1,217 Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-10-29T11:45:26+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Is Amgen Poised for Growth After Recent 4% Price Dip? - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Is Amgen Poised for Growth After Recent 4% Price Dip?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-10-28T16:28:40+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "With questions surrounding its gastric cancer drug, Amgen fills in some gaps - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMie0FVX3lxTE1zNDBYYlJHWGU3TktJb1dpeUI0MkUxZFBpQklTbW1YT3BWWGw4RjVNSm5BOFBZTUJDamRmNUg3bVJaOHhqV21QZXF0MzdBOU14V1JVZVhseWNaSTI4M2NGa0xkbUJLVHhvel9SWDhYd251Y3l3aFAzZkZndw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMie0FVX3lxTE1zNDBYYlJHWGU3TktJb1dpeUI0MkUxZFBpQklTbW1YT3BWWGw4RjVNSm5BOFBZTUJDamRmNUg3bVJaOHhqV21QZXF0MzdBOU14V1JVZVhseWNaSTI4M2NGa0xkbUJLVHhvel9SWDhYd251Y3l3aFAzZkZndw?oc=5\" target=\"_blank\">With questions surrounding its gastric cancer drug, Amgen fills in some gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2025-10-20T14:52:07+00:00",
      "source": "statnews.com"
    },
    {
      "title": "Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices - The New York Times",
      "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPOGtMT0RzU0RhVGtHcjRGc1ZveDNZOUJLMGh3eVB2S3Eyb21tSUpmczRHUEtmWUYtdnlXVGNFUHN6RUVNa3BtZGNGcG1zVEJaZEZUdi03R2R4VHVENzBxcjhrektwRTNFOWpOSTZuSzFpbkRWZktQeDROQkdiV0RCcnBpRFljTDRXSkhWbklkZFhNLW8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxPOGtMT0RzU0RhVGtHcjRGc1ZveDNZOUJLMGh3eVB2S3Eyb21tSUpmczRHUEtmWUYtdnlXVGNFUHN6RUVNa3BtZGNGcG1zVEJaZEZUdi03R2R4VHVENzBxcjhrektwRTNFOWpOSTZuSzFpbkRWZktQeDROQkdiV0RCcnBpRFljTDRXSkhWbklkZFhNLW8?oc=5\" target=\"_blank\">Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The New York Times</font>",
      "published": "2025-10-23T09:00:45+00:00",
      "source": "The New York Times"
    },
    {
      "title": "ESMO 2025 – bemarituzumab fails to convince | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPME91bWdtOGVBLW54MmFCaWJ5UEcxaDFycnZuZXJBMlhUUXZyUndFckw0OTR1VjhHajV1VHlWSlJaX3l3bWRTUS1PbGwtVjR3V0ZoaXRUYXMxV3dZbUdUa1E1TDhMWWRCRmcwNnlKVlpVRm9rYmRQNy1SY2hSa1diaThJXzVfS1E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxPME91bWdtOGVBLW54MmFCaWJ5UEcxaDFycnZuZXJBMlhUUXZyUndFckw0OTR1VjhHajV1VHlWSlJaX3l3bWRTUS1PbGwtVjR3V0ZoaXRUYXMxV3dZbUdUa1E1TDhMWWRCRmcwNnlKVlpVRm9rYmRQNy1SY2hSa1diaThJXzVfS1E?oc=5\" target=\"_blank\">ESMO 2025 – bemarituzumab fails to convince | ApexOnco - Clinical Trials news and analysis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Oncology Pipeline</font>",
      "published": "2025-10-21T13:50:35+00:00",
      "source": "Oncology Pipeline"
    },
    {
      "title": "US FDA expands use of Amgen, AstraZeneca's drug for chronic inflammatory sinus disease - Reuters",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPdHIxQV8zM2pKOENLQm1ULVdWcXd6b2wzYzhxd3p2aHE5ZTd5RWs0UWx6QTd1VDJ1RXpkbUVUWG1JT3UzSmZrVER6OUVMNFNSZXFGa2FWdmpaVWxsVVl3VFNhS1hydC1YaDgwTDdob3l1dFBFaU9PZTVwUXpsM3AteGZ2ZjhFd2FJYWlfbzFWcUxacFFPOU9rQUNNWXprUUZmTTQwRHpzcjRRZTV0ZEQ3QWdRMkpYNW9GUDlwcnY4d3ROTEE0bS1tZldB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxPdHIxQV8zM2pKOENLQm1ULVdWcXd6b2wzYzhxd3p2aHE5ZTd5RWs0UWx6QTd1VDJ1RXpkbUVUWG1JT3UzSmZrVER6OUVMNFNSZXFGa2FWdmpaVWxsVVl3VFNhS1hydC1YaDgwTDdob3l1dFBFaU9PZTVwUXpsM3AteGZ2ZjhFd2FJYWlfbzFWcUxacFFPOU9rQUNNWXprUUZmTTQwRHpzcjRRZTV0ZEQ3QWdRMkpYNW9GUDlwcnY4d3ROTEE0bS1tZldB?oc=5\" target=\"_blank\">US FDA expands use of Amgen, AstraZeneca's drug for chronic inflammatory sinus disease</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-10-17T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S. - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxQaXdzbXE0cjkzTHVJWHJtenlXSDlybk42SDJCWnkzYVM0MzdlQlJiVGRkUUQtNkUtcHBxTVlqamVtazJ3WnhyZWlReUdXMDdIZ0FHemxuek5MZmdoWG52Z0l3OGszU2RjMGJsODJJbURPTEswYklJUXY4dFRaR2VvcnNvNGVORExLRE41UmhwRmwwdlRzUzM2YmpxRFhXM1JvU0hZM3NSakdza2Q1dmFMQWh1WXdoOVdqak9iZklDdE10d21FVC1GdjBOX1Y1clI3V1lqd1RKdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQaXdzbXE0cjkzTHVJWHJtenlXSDlybk42SDJCWnkzYVM0MzdlQlJiVGRkUUQtNkUtcHBxTVlqamVtazJ3WnhyZWlReUdXMDdIZ0FHemxuek5MZmdoWG52Z0l3OGszU2RjMGJsODJJbURPTEswYklJUXY4dFRaR2VvcnNvNGVORExLRE41UmhwRmwwdlRzUzM2YmpxRFhXM1JvU0hZM3NSakdza2Q1dmFMQWh1WXdoOVdqak9iZklDdE10d21FVC1GdjBOX1Y1clI3V1lqd1RKdw?oc=5\" target=\"_blank\">AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "PR Newswire"
    }
  ],
  "product_launches": [
    {
      "title": "Endo Launches First Generic Version of Amgen’s RAVICTI, Expanding Access for Rare Disease Patients - MyChesCo",
      "link": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxNejJnZmFlNXA2dGd5ZDhMY3JHY25lNW9CNmV2SHkzVThEZ2YtbUp0RHVXYmVRUjUyNzFLc0RicXdCQkl5blVxRWNCbzdxWEFMQ3lHNWlocFc2SFNUcC1hNHZSOGF4aVhJaEtQNzYzMTR2QWxtMXFMMlFGcnV2N0VHNDAzQVFHMUNyTjJuTE5BOEZjdWlZdFMzc2hoUVBPZkRUQnBzUWp4MUk4WFFDRlJQZl9JeEtKbzFHRFl2ZER6WEVMa1E2eFV3RmhtTzZhMUVXdXRBdGpxdThYQklWWHFDTF9rSXNObVo4d0tlbw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNejJnZmFlNXA2dGd5ZDhMY3JHY25lNW9CNmV2SHkzVThEZ2YtbUp0RHVXYmVRUjUyNzFLc0RicXdCQkl5blVxRWNCbzdxWEFMQ3lHNWlocFc2SFNUcC1hNHZSOGF4aVhJaEtQNzYzMTR2QWxtMXFMMlFGcnV2N0VHNDAzQVFHMUNyTjJuTE5BOEZjdWlZdFMzc2hoUVBPZkRUQnBzUWp4MUk4WFFDRlJQZl9JeEtKbzFHRFl2ZER6WEVMa1E2eFV3RmhtTzZhMUVXdXRBdGpxdThYQklWWHFDTF9rSXNObVo4d0tlbw?oc=5\" target=\"_blank\">Endo Launches First Generic Version of Amgen’s RAVICTI, Expanding Access for Rare Disease Patients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MyChesCo</font>",
      "published": "2025-10-27T04:00:00+00:00",
      "source": "MyChesCo"
    },
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "$239/month for Repatha — AmgenNow direct-to-patient program offers nearly 60% discount in U.S. - Stock Titan",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNX1VmYlB3RmtYTG5rd1dJblFhNVh6UEFHdzkxTm9VRy0wMVc1SDNuZ0JLYUNRTHA0VVhBOEpWb1RUa2FONTVMY19CSTJSVVJSUjFwbkIwMFdtalFEWHRmQTVvQnFzY3YxYUFqaDc2cjBydnV0RjdSWGhCTzdaWDl1Y2VNVU9LdzZvLW1FZHhnam12Qm1XaEg0M3ZEeTh4aHNkcUZsazNRa0tuTGY3WXNiZjZKSnh2SkJRVVl6OXRR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxNX1VmYlB3RmtYTG5rd1dJblFhNVh6UEFHdzkxTm9VRy0wMVc1SDNuZ0JLYUNRTHA0VVhBOEpWb1RUa2FONTVMY19CSTJSVVJSUjFwbkIwMFdtalFEWHRmQTVvQnFzY3YxYUFqaDc2cjBydnV0RjdSWGhCTzdaWDl1Y2VNVU9LdzZvLW1FZHhnam12Qm1XaEg0M3ZEeTh4aHNkcUZsazNRa0tuTGY3WXNiZjZKSnh2SkJRVVl6OXRR?oc=5\" target=\"_blank\">$239/month for Repatha — AmgenNow direct-to-patient program offers nearly 60% discount in U.S.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stock Titan</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "Stock Titan"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-10-28",
      "close": 292.0899963378906
    },
    "history": [
      {
        "date": "2025-10-20",
        "close": 303.3299865722656
      },
      {
        "date": "2025-10-21",
        "close": 301.1400146484375
      },
      {
        "date": "2025-10-22",
        "close": 295.9800109863281
      },
      {
        "date": "2025-10-23",
        "close": 292.8900146484375
      },
      {
        "date": "2025-10-24",
        "close": 291.760009765625
      },
      {
        "date": "2025-10-27",
        "close": 291.1600036621094
      },
      {
        "date": "2025-10-28",
        "close": 292.0899963378906
      }
    ],
    "name": "Amgen Inc."
  }
}